FFA
MRVI icon

Farther Finance Advisors’s Maravai LifeSciences MRVI Stock Holding History

Farther Finance Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26K Sell
4,113
-691
-14% -$2.98K ﹤0.01% 3785
2026
Q1 		$13.8K Sell
4,804
-255
-5% -$865 ﹤0.01% 3907
2025
Q4 		$16.4K Sell
5,059
-13,698
-73% -$46.1K ﹤0.01% 3568
2025
Q3 		$53.8K Buy
18,757
+10,982
+141% +$28K ﹤0.01% 2395
2025
Q2 		$18.7K Buy
7,775
+7,653
+6,273% +$16.1K ﹤0.01% 2719
2025
Q1 		$264 Sell
122
-10,074
-99% -$39.8K ﹤0.01% 3901
2024
Q4 		$55.6K Buy
10,196
+9,916
+3,541% +$63.8K ﹤0.01% 1607
2024
Q3 		$2.33K Buy
280
+30
+12% +$259 ﹤0.01% 2944
2024
Q2 		$1.74K Buy
250
+122
+95% +$1.05K ﹤0.01% 2852
2024
Q1 		$1.1K Sell
128
-93
-42% -$629 ﹤0.01% 2734
2023
Q4 		$1.45K Buy
221
+121
+121% +$782 ﹤0.01% 2569
2023
Q3 		$1K Buy
100
+90
+900% +$988 ﹤0.01% 2083
2023
Q2 		$124 Hold
10
– – ﹤0.01% 2413
2023
Q1 		$140 Buy
+10
New +$144 ﹤0.01% 2259

Other funds holding MRVI

DRP
Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Farther Finance Advisors's MRVI Position: Q2 2026 in Review

Farther Finance Advisors reduced its Maravai LifeSciences (MRVI) stake by 14% in Q2 2026, selling an estimated $2.98K and leaving 4,113 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3785.

Farther Finance Advisors first reported a position in MRVI in Q1 2023 and has held it in 14 quarters since. The position peaked at $55.6K in Q4 2024. 7 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Farther Finance Advisors held 4,113 shares of Maravai LifeSciences worth $26K as of Q2 2026.
  • Farther Finance Advisors sold 691 Maravai LifeSciences shares in Q2 2026, an estimated $2.98K.
  • Maravai LifeSciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3785 holding.
  • Farther Finance Advisors first reported a position in Maravai LifeSciences in Q1 2023 and has held it in 14 quarters since.
  • Farther Finance Advisors's Maravai LifeSciences position peaked at $55.6K in Q4 2024.
  • 7 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.